GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (MEX:TNDM) » Definitions » Cyclically Adjusted Price-to-FCF

Tandem Diabetes Care (MEX:TNDM) Cyclically Adjusted Price-to-FCF : (As of Sep. 26, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tandem Diabetes Care Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Tandem Diabetes Care Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care Cyclically Adjusted Price-to-FCF Chart

Tandem Diabetes Care Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tandem Diabetes Care Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF falls into.



Tandem Diabetes Care Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Tandem Diabetes Care's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Tandem Diabetes Care's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-3.309/132.5538*132.5538
=-3.309

Current CPI (Jun. 2024) = 132.5538.

Tandem Diabetes Care Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 -83.245 100.428 -109.874
201412 -89.344 99.070 -119.541
201503 -96.153 99.621 -127.939
201506 -107.622 100.684 -141.688
201509 -90.458 100.392 -119.438
201512 -67.914 99.792 -90.210
201603 -101.670 100.470 -134.136
201606 -94.590 101.688 -123.301
201609 -128.102 101.861 -166.702
201612 -109.029 101.863 -141.879
201703 -138.487 102.862 -178.462
201706 -58.075 103.349 -74.486
201709 -67.354 104.136 -85.735
201712 -25.347 104.011 -32.303
201803 -12.910 105.290 -16.253
201806 -2.814 106.317 -3.508
201809 -1.503 106.507 -1.871
201812 4.520 105.998 5.652
201903 -1.857 107.251 -2.295
201906 -1.054 108.070 -1.293
201909 6.135 108.329 7.507
201912 4.042 108.420 4.942
202003 -10.753 108.902 -13.088
202006 0.347 108.767 0.423
202009 2.773 109.815 3.347
202012 3.560 109.897 4.294
202103 8.236 111.754 9.769
202106 5.381 114.631 6.222
202109 9.855 115.734 11.287
202112 4.397 117.630 4.955
202203 3.478 121.301 3.801
202206 -1.799 125.017 -1.907
202209 0.593 125.227 0.628
202212 0.058 125.222 0.061
202303 -8.141 127.348 -8.474
202306 -3.759 128.729 -3.871
202309 -1.430 129.860 -1.460
202312 -9.010 129.419 -9.228
202403 -3.164 131.776 -3.183
202406 -3.309 132.554 -3.309

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tandem Diabetes Care  (MEX:TNDM) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Tandem Diabetes Care Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Tandem Diabetes Care's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tandem Diabetes Care Business Description

Traded in Other Exchanges
Address
11075 Roselle Street, San Diego, CA, USA, 92121
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.